CC(C)(C)C(=O)O[C@H]1CC[C@@]2(C)C(=CC(=O)C3C4C[C@@H](O)C(=O)[C@@]4(C)CCC32)C1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?